Adjust dosage according to blood pressure response after 2–4 weeks of treatment. Coadministration of ribavirin and zidovudine is not advised. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. By using this Site you agree to the following We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Subscribe to MedHelp's free newsletter for Community Support, Experience, and Guidance. In treatment of mono-infected HCV patients the combi nation PEG-IFN alfa-2a and ribavirin has been found to be more effective than PEG-IFN alfa-2a alone, and the ribavirin dose of either 1000 mg or 1200 mg, depending on patient weight, has been found to be more effective in mono-infected patients than the do se of 800 mg. If studies were underway in … After oral administration of 600 mg of 14 C-ribavirin, approximately 61% and 12% of the radioactivity was eliminated in the urine and feces, respectively, in 336 hours. Copyright © Vitals Consumer Services LLC It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Subscribe to MedHelp's free newsletter for Community Support, Experience, and Guidance. By using this Site you agree to the following The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. IV ribavirin was reviewed for diseases treated, reported clinical outcomes, and AEs. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. School University of Toronto; Course Title PHM 150; Type. The package insert says that Ribavirin should be considered a potential carcinogen. Hypertension: Initial dose is 2.5 mg to 20 mg once daily. If studies were underway in … We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Package Insert (218859)_Version 56 CONFIDENTIAL Page 1 of 30 CSL Behring Immune Globulin Intravenous (Human), 10% Liquid, Privigen 1.14.1.3 Draft Labeling Text The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. Ribavirin and its triazole carboxamide and triazole carboxylic acid metabolites are excreted renally. By using this Site you agree to the following Unchanged ribavirin accounted for 17% of the administered dose. The package insert says that Ribavirin should be considered a potential carcinogen. Notes. The package also says that further studies are being conducted; however, the package insert is copyrighted 1998, and bears a revision date of 8/01. We offer this Site AS IS and without any warranties. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. The package also says that further studies are being conducted; however, the package insert is copyrighted 1998, and bears a revision date of 8/01. Copyright © Vitals Consumer Services LLC Adverse events reported in the literature were compared with AEs listed in approved product labeling (aerosol and oral formulations). By using this Site you agree to the following From February 1997 to December 2008, 608 IV ribavirin EIND requests were made for 19 disease conditions. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Exacerbation of anemia has been reported in HIV-1/HCV co-infected patients receiving ribavirin and zidovudine.